Título:
Genetic characterization of Lynch syndrome germline variants in a LATAM cohort using a customized NGS gene panel
Otros títulos:
Coordinador:
Director:
Compilador:
Autor:
Mathó, Cecilia
Chávez, Santiago
Fort Canobra, Rafael S
Della Valle, Adriana
Neffa, Florencia
Sotelo-Silveira, José Roberto
Artagaveytia, Nora
Duhagon, María Ana
Chávez, Santiago
Fort Canobra, Rafael S
Della Valle, Adriana
Neffa, Florencia
Sotelo-Silveira, José Roberto
Artagaveytia, Nora
Duhagon, María Ana
Tutor:
Tipo de documento:
Artículo
Editor:
Palabras clave:
Lynch Syndrome
Colorectal cancer
LATAM
NGS
Novel variants
Germline cancer predisposition
Colorectal cancer
LATAM
NGS
Novel variants
Germline cancer predisposition
Descriptores:
Año de publicación:
2025
Contenido:
Resumen:
Introduction: Lynch Syndrome accounts for 1–7% of all colorectal cancers and is caused by germline mutations in DNA mismatch repair (MMR) genes. Timely molecular diagnosis is crucial for effective genetic counseling and management. Among understudied Latin American populations, Uruguay’s genetic admixture provides an opportunity to identify novel Lynch Syndrome related variants.
Methods: This study analyzed 70 unrelated Uruguayan colorectal cancer patients meeting Lynch Syndrome clinical criteria to identify carriers of pathogenic variants. A customized Next-Generation Sequencing (NGS) panel was
developed and sequenced on the Ion Torrent platform to analyze nine genes: MLH1, MSH2, MSH6, EPCAM, FAN1, MUTYH, PMS1, PMS2, and APC. Copy number variations and large EPCAM deletions are not detected by the assay. Gene variants were prioritized based on allelic frequency, in silico predictions, pathogenicity records, and ACMG guidelines. The performance of this custom NGS panel was evaluated for in-house applications, and its limitations were thoroughly assessed.
Results and discussion: The custom NGS panel demonstrated effectiveness for scalable in-house testing despite minor disclosed sequence coverage limitations. Pathogenic and likely pathogenic variants were identified in 25 patients, including four novel Lynch Syndrome-associated variants. In four patients, a rare ambiguously classified gene variant co-occurs with a known pathogenic variant in another gene. The mutation profile correlated with clinical
parameters such as age of diagnosis, diagnosis criteria, tumor location, and microsatellite instability (MSI). Conclusion: This is the most comprehensive genetic study to date on a Uruguayan Lynch syndrome cohort. The mutational landscape aligns with findings in other populations while highlighting novel variants of clinical relevance. These findings highlight the value of customized panels for improving genetic screening in small-scale healthcare facilities.
Descripción:
metadata.articulos.dc.description.uri:
Editorial:
Frontiers
EN:
Frontiers in Oncology, 2025, 15: 1589765.
Financiadores:
Citación:
Mathó, C, Chávez, S, Fort Canobra, R [y otros autores]. "Genetic characterization of Lynch syndrome germline variants in a LATAM cohort using a customized NGS gene panel". Frontiers in Oncology. [en línea] 2025, 15: 1589765. 14 h. DOI: 10.3389/fonc.2025.1589765
Citación:
metadata.articulos.cc.license.name:
ISBN:
e-ISBN:
ISSN:
2234-943X
ISMN:
Otros identificadores:
Cobertura geográfica:
Cobertura temporal:
Departamento académico:
Grupo de investigación:
Licencia:
Licencia Creative Commons Atribución (CC - By 4.0)
Colecciones:
| Ficheros | Descripción | Tamaño | Formato | ||
|---|---|---|---|---|---|
| 10.3389.fonc.2025.1589765.pdf | — | 1.77 MB | Adobe PDF |
